Literature DB >> 11125320

Ingredients and safety of cellulite creams.

E L Sainio1, T Rantanen, L Kanerva.   

Abstract

There is virtually no knowledge of the ingredients of cellulite creams in the dermatological literature. In the present study, the ingredients of cellulite creams, the frequency of their use and whether the ingredients have been reported to cause allergy were investigated. In the 32 products tested, 263 ingredients were used. On average each product contained 22 ingredients (range 4 to 31). Botanicals and emollients predominated; altogether 44 different botanicals and 39 different emollients were used in the 32 products. Caffeine, present in 14 products was the most common additive, apparently representing an "active" ingredient. In other respects the compositions of the products were similar to those of skin creams. All products contained fragrance. The creams were microbiologically pure. Concentrations of preservatives did not exceed limit values in the regulations. No formaldehyde was present (detection limit 10 ppm). The well-known allergens isothiazolinones or dibromoglutaronitril were declared only in a few products. In spite of the large number of substances used in cellulite creams, their safety seems acceptable for most users. Because, however, one fourth of the substances used have been shown to cause allergy, the risk of adverse effects should be taken into account when using cellulite creams.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11125320

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  3 in total

1.  [Anti-aging. The pretty leg].

Authors:  H Stege
Journal:  Hautarzt       Date:  2005-04       Impact factor: 0.751

2.  Microfocused Ultrasound with Visualization and Calcium Hydroxylapatite for Improving Skin Laxity and Cellulite Appearance.

Authors:  Gabriela Casabona; Gregório Pereira
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-07-25

Review 3.  Can cellulite be treated with low-energy extracorporeal shock wave therapy?

Authors:  Fiorenzo Angehrn; Christoph Kuhn; Axel Voss
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.